These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15184946)

  • 1. Ocular-hypertensive response and corneal endothelial changes after intravitreal triamcinolone injections in Chinese subjects: a 6-month follow-up study.
    Chan CK; Fan DS; Chan WM; Lai WW; Lee VY; Lam DS
    Eye (Lond); 2005 Jun; 19(6):625-30. PubMed ID: 15184946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of intravitreal triamcinolone on intraocular pressure.
    Kramar M; Vu L; Whitson JT; He YG
    Curr Med Res Opin; 2007 Jun; 23(6):1253-8. PubMed ID: 17559723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection.
    Im L; Allingham RR; Singh I; Stinnett S; Fekrat S
    J Glaucoma; 2008 Mar; 17(2):128-32. PubMed ID: 18344759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
    Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF
    Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal triamcinolone will cause posterior subcapsular cataract in most eyes with diabetic maculopathy within 2 years.
    Islam MS; Vernon SA; Negi A
    Eye (Lond); 2007 Mar; 21(3):321-3. PubMed ID: 16543927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors.
    Vasconcelos-Santos DV; Nehemy PG; Schachat AP; Nehemy MB
    Retina; 2008 Apr; 28(4):573-80. PubMed ID: 18398360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term incidence and timing of intraocular hypertension after intravitreal triamcinolone acetonide injection.
    Roth DB; Verma V; Realini T; Prenner JL; Feuer WJ; Fechtner RD
    Ophthalmology; 2009 Mar; 116(3):455-60. PubMed ID: 19157561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of patient age as a risk factor for intraocular pressure elevation after intravitreal triamcinolone.
    Shukla D; Vidhya N; Prasad NM; Mahalakshmi R; Kolluru C; Krishnadas R
    Am J Ophthalmol; 2007 Sep; 144(3):453-4. PubMed ID: 17765428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phacoemulsification with intravitreal triamcinolone in patients with cataract and coexisting diabetic macular oedema: a 6-month prospective pilot study.
    Lam DS; Chan CK; Mohamed S; Lai TY; Lee VY; Lai WW; Fan DS; Chan WM
    Eye (Lond); 2005 Aug; 19(8):885-90. PubMed ID: 15389275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
    Jonas JB
    Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary elevated IOP and cataracts after high-dose intravitreal triamcinolone and photodynamic therapy to treat choroidal neovascularization.
    Ruiz-Moreno JM; Montero JA; Amat P; Lugo FL
    J Glaucoma; 2009 Jan; 18(1):69-72. PubMed ID: 19142138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraocular pressure after intravitreal injection of triamcinolone acetonide following vitrectomy for macular edema.
    Yamashita T; Uemura A; Kita H; Sakamoto T
    J Glaucoma; 2007 Mar; 16(2):220-4. PubMed ID: 17473734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
    Dusová J; Studnicka J; Rencová E; Korda V; Hejcmanová D
    Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
    Jonas JB; Degenring RF; Kreissig I; Akkoyun I; Kamppeter BA
    Ophthalmology; 2005 Apr; 112(4):593-8. PubMed ID: 15808249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.
    Lin JM; Chiu YT; Hung PT; Tsai YY
    Retina; 2007 Feb; 27(2):180-9. PubMed ID: 17290200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative use of intravitreal triamcinolone in uveitic eyes having cataract surgery: pilot study.
    Okhravi N; Morris A; Kok HS; Menezo V; Dowler JG; Hykin PG; Lightman S
    J Cataract Refract Surg; 2007 Jul; 33(7):1278-83. PubMed ID: 17586387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract.
    Gillies MC; Kuzniarz M; Craig J; Ball M; Luo W; Simpson JM
    Ophthalmology; 2005 Jan; 112(1):139-43. PubMed ID: 15629834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Variations in intraocular pressure (IOP) and necessity for paracentesis following intravitreal triamcinolone injection].
    Dwinger MC; Pieper-Bodeewes I; Eter N; Holz FG
    Klin Monbl Augenheilkd; 2005 Aug; 222(8):638-42. PubMed ID: 16118744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of a topical dexamethasone provocative test before intravitreal triamcinolone acetonide injection.
    Breusegem C; Vandewalle E; Van Calster J; Stalmans I; Zeyen T
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):573-6. PubMed ID: 18824737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.